ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » California » Critical Care Medicine

Top Critical Care Medicine Prescribers in California

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
FIKIR MORKOC M.D.

Critical Care Medicine

13,994

$720K

666
411 are 65+

4%
patients receiving schedule two controlled substances

Avg: 0%

16%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 57%

$51
Average prescription price

Avg: $167

HANKYU CHUNG M.D.

Critical Care Medicine

7,553

$401K

317
303 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 57%

$53
Average prescription price

Avg: $167

PARYUS PATEL MD

Critical Care Medicine

7,369

$704K

343
267 are 65+

6%
patients receiving schedule two controlled substances

Avg: 0%

20%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 57%

$96
Average prescription price

Avg: $167

MANOHAR SENRA M.D.

Critical Care Medicine

6,959

$402K

223
196 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

18%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 57%

$58
Average prescription price

Avg: $167

BARZAN MOHEDIN MD

Critical Care Medicine

5,426

$357K

246
219 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

9%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 57%

$66
Average prescription price

Avg: $167

JAMES OTOSHI MD

Critical Care Medicine

5,415

$505K

166
131 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 57%

$93
Average prescription price

Avg: $167

RAMESH KARODY M.D. INC

Critical Care Medicine

4,674

$237K

174
144 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

16%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 57%

$51
Average prescription price

Avg: $167

DARLENE ELIAS M.D.

Critical Care Medicine

3,898

$249K

924
852 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 57%

$64
Average prescription price

Avg: $167

JOEL HANDLER MD

Critical Care Medicine

3,393

$127K

343
329 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 57%

$37
Average prescription price

Avg: $167

THEODOR PARADA M.D.

Critical Care Medicine

3,123

$411K

123
113 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

24%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

39%
prescriptions for brand name drugs

Avg: 57%

$132
Average prescription price

Avg: $167

SRIRAM SAMBASIVAN M.D.

Critical Care Medicine

3,103

$380K

319
191 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 57%

$123
Average prescription price

Avg: $167

BOBBAK VAHID MD

Critical Care Medicine

2,866

$182K

198
157 are 65+

6%
patients receiving schedule two controlled substances

Avg: 0%

12%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 57%

$63
Average prescription price

Avg: $167

MIR MADANI M.D.

Critical Care Medicine

2,622

$226K

185
166 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

10%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 57%

$86
Average prescription price

Avg: $167

MARCY ZWELLING MD

Critical Care Medicine

2,427

$339K

107
95 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

14%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

46%
prescriptions for brand name drugs

Avg: 57%

$140
Average prescription price

Avg: $167

DARSHANA KADAKIA MD

Critical Care Medicine

2,360

$117K

112
92 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

10%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 57%

$50
Average prescription price

Avg: $167

MOHAMED LATIF M.D.

Critical Care Medicine

2,303

$206K

174
159 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 57%

$89
Average prescription price

Avg: $167

JEFFREY KRAHLING M.D.

Critical Care Medicine

2,300

$295K

258
151 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

11%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 57%

$128
Average prescription price

Avg: $167

RAFAEL LUPERCIO M.D.

Critical Care Medicine

2,121

$997K

370
284 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

57%
prescriptions for brand name drugs

Avg: 57%

$470
Average prescription price

Avg: $167

GUNDEEP DHILLON MD

Critical Care Medicine

1,929

$783K

95
38 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 57%

$406
Average prescription price

Avg: $167

JACQUELINE CHANG M.D.

Critical Care Medicine

1,896

$480K

257
232 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

64%
prescriptions for brand name drugs

Avg: 57%

$253
Average prescription price

Avg: $167

DOUGLAS TAPPER MD

Critical Care Medicine

1,860

$310K

272
237 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

38%
prescriptions for brand name drugs

Avg: 57%

$167
Average prescription price

Avg: $167

ARIAN TORBATI MD

Critical Care Medicine

1,824

$365K

424
385 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

69%
prescriptions for brand name drugs

Avg: 57%

$200
Average prescription price

Avg: $167

CRAIG ARAKAKI MD

Critical Care Medicine

1,800

$500K

248
221 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

54%
prescriptions for brand name drugs

Avg: 57%

$278
Average prescription price

Avg: $167

SIGAL TENE MD

Critical Care Medicine

1,629

$283K

148
138 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

52%
prescriptions for brand name drugs

Avg: 57%

$174
Average prescription price

Avg: $167

SHARAD DASS M.D.

Critical Care Medicine

1,610

$230K

91
82 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

41%
prescriptions for brand name drugs

Avg: 57%

$143
Average prescription price

Avg: $167

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank